Clinical Trial Oversight Training Programs For IRBs Recommended By BIO
Executive Summary
Institutional Review Boards need better training for clinical trial oversight, not new rules governing procedures, the Biotechnology Industry Organization suggests
You may also be interested in...
Human Subject Protection Law Likely After “Building Block” Year – BIO
BIO is preparing for legislative activity on human subject protection in the next Congress, Genentech Government Affairs Director Heidi Wagner told the Biotechnology Industry Organization annual meeting June 10 in Toronto
Human Subject Protection Law Likely After “Building Block” Year – BIO
BIO is preparing for legislative activity on human subject protection in the next Congress, Genentech Government Affairs Director Heidi Wagner told the Biotechnology Industry Organization annual meeting June 10 in Toronto
Greenwood/DeGette Human Subject Protection Bill Has Support Of ACRO
HHS would be directed to harmonize FDA's clinical trial oversight regulations with the common rule under the Greenwood/DeGette human subject protection bill